Using ipatasertib, researchers say some brain cancers could potentially be made vulnerable to immunotherapy agent
Two people with advanced brain cancer of the sort that led to the death of the MP Tessa Jowell have responded well in a small trial to an experimental combination of chemo and immunotherapy drugs. In one case, the life-threatening tumour seems to have disappeared.
Doctors at the Institute of Cancer Research and the Royal Marsden hospital in London cautioned that this is very early research but said it was unusual to have such a good response in patients in an early trial.
